Patient-Reported QOL Outcomes of Hypofractionated Stereotactic Body Radiation Therapy Boost for the Treatment of Localized, Non-Metastatic, High-Risk Prostate Cancer: Updated Results of a Phase II Trial
2020 ◽
Vol 108
(3)
◽
pp. e907-e908
2018 ◽
Vol 102
(3)
◽
pp. S105-S106
2018 ◽
Vol 102
(3)
◽
pp. e121-e122
2020 ◽
Vol 108
(4)
◽
pp. 930-935
2016 ◽
Vol 95
(3)
◽
pp. 960-964
◽
2020 ◽
Vol 108
(3)
◽
pp. e899-e900
2015 ◽
Vol 91
(4)
◽
pp. 832-839
◽